Implementation Reports 14, no. 6 (2016): 196–237.
35. de Baaij, J. H., J. G. Hoenderop, and R. J. Bindels. “Magnesium in Man: Implications for Health and Disease.” Physiological Reviews 95, no. 1 (2015): 1–46.
36. DiNicolantonio, J. J., J. H. O’Keefe, and W. Wilson. “Subclinical Magnesium Deficiency: A Principal Driver of Cardiovascular Disease and a Public Health Crisis.” Open Heart 5, no. 1 (2018): e000668.
37. Guoa, W., et al. “Magnesium Deficiency on Plants: An Urgent Problem.” The Crop Journal 4, no. 2 (2016): 83–91; Thomas, D. “The Mineral Depletion of Foods Available to Us as a Nation (1940–2002) – A Review of the 6th Edition of McCance and Widdowson.” Nutrition and Health 19, no. 1–2 (2007): 21–55.
38. Temple, N. J. “Refined Carbohydrates – A Cause of Suboptimal Nutrient Intake.” Medical Hypotheses 10, no. 4 (1983): 411–424.
39. Costello, R. B., et al. “Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.” Advances in Nutrition 7, no. 6 (2016): 977–993.
40. Marier, J. R. “Magnesium Content of the Food Supply in the Modern-Day World.” Magnesium 5, no. 1 (1986): 1–8.
41. Tipton, I. H., P. L. Stewart, and J. Dickson. “Patterns of Elemental Excretion in Long Term Balance Studies.” Health Physics 16, no. 4 (1969): 455–462.
42. См. примечание 39 выше.
43. См. примечание 36 выше.
44. Rayssiguier, Y., et al. “Dietary Magnesium Affects Susceptibility of Lipoproteins and Tissues to Peroxidation in Rats.” The Journal of the American College of Nutrition 12, no. 2 (1993): 133–137; Bussiere, L., et al. “Triglyceride-Rich Lipoproteins from Magnesium-Deficient Rats Are More Susceptible to Oxidation by Cells and Promote Proliferation of Cultured Vascular Smooth Muscle Cells.” Magnesium Research 8, no. 2 (1995): 151–7; Turlapaty, P. D., and B. M. Altura. “Magnesium Deficiency Produces Spasms of Coronary Arteries: Relationship to Etiology of Sudden Death Ischemic Heart Disease.” Science 208, no. 4440 (1980): 198–200.
45. См. примечание 36 выше.
46. См. примечание 36 выше.
47. Kodama, N., M. Nishimuta, and K. Suzuki. “Negative Balance of Calcium and Magnesium Under Relatively Low Sodium Intake in Humans.” Journal of Nutritional Science and Vitaminology (Tokyo) 49, no. 3 (2003): 201–209.
48. См. примечание 47 выше.
49. Nishimuta, M., et al. “Positive Correlation Between Dietary Intake of Sodium and Balances of Calcium and Magnesium in Young Japanese Adults – Low Sodium Intake Is a Risk Factor for Loss of Calcium and Magnesium.” Journal of Nutritional Science and Vitaminology (Tokyo) 51, no. 4 (2005): 265–270.
50. Delva, P., et al. “Intralymphocyte Free Magnesium in Patients with Primary Aldosteronism: Aldosterone and Lymphocyte Magnesium Homeostasis.” Hypertension 35, no. 1 Pt 1 (2000): 113–117.
51. Durlach, J. “Recommended Dietary Amounts of Magnesium: Mg RDA.” Magnesium Research 2, no. 3 (1989): 195–203.
52. См. примечание 36 выше.
53. Rosanoff, A. “Magnesium and Hypertension.” Clinical Calcium 15, no. 2 (2005): 255–260.
54. См. примечание 36 выше.
55. Schuette, S. A., B. A. Lashner, and M. Janghorbani. “Bioavailability of Magnesium Diglycinate vs Magnesium Oxide in Patients with Ileal Resection.” Journal of Parenteral and Enteral Nutrition 18, no. 5 (1994): 430–435.
56. Spasov, A. A., et al. “Comparative Study of Magnesium Salts Bioavailability in Rats Fed a Magnesium-Deficient Diet.” Vestnik Rossiiskoi Akademii Meditsinskikh Nauk no. 2 (2010): 29–37; Guillard, O., et al. “Unexpected Toxicity Induced by Magnesium Orotate Treatment in Congenital Hypomagnesemia.” Journal of Internal Medicine 252, no. 1 (2002): 88–90.
57. Ibid.
58. Phillips, R., et al. “Citrate Salts for Preventing and Treating Calcium Containing Kidney Stones in Adults.” Cochrane Database of Systematic Reviews no. 10 (2015): Cd010057.
59. Stepura, O. B., and A. I. Martynow. “Magnesium Orotate in Severe Congestive Heart Failure (MACH).” International Journal of Cardiology 131, no. 2 (2009): 293–295.
Глава 11
1. Harcombe, Z., et al. “Evidence from Randomised Controlled Trials Did Not Support the Introduction of Dietary Fat Guidelines in 1977 and 1983: A Systematic Review and Meta-Analysis.” Open Heart 2, no. 1 (2015): e000196; Harcombe, Z., et al. “Evidence from Randomised Controlled Trials Does Not Support Current Dietary Fat Guidelines: A Systematic Review and Meta-Analysis.” Open Heart 3, 2 (2016): e000409; DiNicolantonio, J. J. “The Cardiometabolic Consequences of Replacing Saturated Fats with Carbohydrates or Ω-6 Polyunsaturated Fats: Do the Dietary Guidelines Have It Wrong?” Open Heart 1 (2014): e000032. doi:10.1136/openhrt-2013-000032; Ravnskov, U., et al. “The Questionable Benefits of Exchanging Saturated Fat with Polyunsaturated Fat.” Mayo Clinic Proceedings 89, no. 4 (2014): 451–453.
2. Teicholtz, N. The Big Fat Surprise: Why Butter, Meat and Cheese Belong in a Healthy Diet. New York: Simon & Schuster, 2014.
3. Barbee, M. Politically Incorrect Nutrition: Finding Reality in the Mire of Food Industry Propaganda. Garden City Park, NY: Square One Publishers, 2004: 27.
4. Bhupathiraju, S. N., and K. L. Tucker. “Coronary Heart Disease Prevention: Nutrients, Foods, and Dietary Patterns.” Clinica Chimica Acta 412, no. 17–18 (2011): 1493–1514.
5. Sun, Q., et al. “A Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease.” Circulation 115, no. 14 (2007): 1858–1865; Block, R. C., et al. “Omega-6 and Trans Fatty Acids in Blood Cell Membranes: A Risk Factor for Acute Coronary Syndromes?” American Heart Journal 156, no. 6 (2008): 1117–1123; Willett, W. C., et al. “Intake of Trans Fatty Acids and Risk of Coronary Heart Disease Among Women.” Lancet 341, no. 8845 (1993): 581–555.
6. Grimes, W. “April 24–30; How About Some Popcorn with Your Fat?” The New York Times, May 1, 1994, открыто по адресу www.nytimes.com/1994/05/01/weekinreview/april-24-30-howabout-some-popcorn-with-your-fat.html.
7. Hu, F. B., et al. “Dietary Fat Intake and the Risk of Coronary Heart Disease in Women.” New England Journal of Medicine 337, no. 21 (1997): 1491–1499.
8. Zaloga, G. P., et al. “Trans Fatty Acids and Coronary Heart Disease.” Nutrition in Clinical Practice 21, no. 5 (2006): 505–512.
9. de Souza, R. J., et al. “Intake of Saturated and Trans Unsaturated Fatty Acids and Risk of All Cause Mortality, Cardiovascular Disease, and Type 2 Diabetes: Systematic Review and Meta-Analysis of Observational Studies.” The BMJ 351 (2015): h3978.
10. См. примечание 4 выше.
11. Fox, M. “WHO Urges All Countries to Ban Trans Fats,” May 14,
